Intestinal Microbiome Inhibits CD8+ T Cells via the Calcineurin-NFAT Axis

    Cancer Discovery
    |April 8, 2022
    PubMed

    Insights

    Bacterial sensing triggers the calcineurin-nuclear factor of activated T-cells (NFAT) pathway, which suppresses CD8+ T cell activity in colon cancer. This discovery offers new insights into immune evasion in colorectal tumors.

    Area of Science:

    • Immunology
    • Microbiology
    • Oncology

    Background:

    • CD8+ T cells are crucial for anti-tumor immunity in colorectal cancer.
    • The tumor microenvironment in colon cancer often harbors bacteria that can influence immune responses.
    • Understanding immune checkpoints and bacterial interactions is vital for developing novel cancer therapies.

    Purpose of the Study:

    • To investigate the role of bacterial sensing in modulating CD8+ T cell function within the colon cancer microenvironment.
    • To elucidate the specific molecular pathways, including the calcineurin-NFAT axis, involved in this immune suppression.

    Main Methods:

    • Utilized mouse models of colon cancer with specific bacterial colonization.
    • Employed techniques such as flow cytometry, immunohistochemistry, and molecular assays to analyze T cell activation and signaling pathways.
    • Investigated the impact of inhibiting the calcineurin-NFAT axis on anti-tumor immunity.

    Main Results:

    • Demonstrated that bacterial sensing in colon cancer activates the calcineurin-NFAT signaling pathway.
    • Showed that this activation leads to the inhibition of CD8+ T cell effector functions, impairing anti-tumor responses.
    • Found that blocking the calcineurin-NFAT axis partially restored CD8+ T cell activity against colon tumors.

    Conclusions:

    • Bacterial sensing represents a significant mechanism for immune evasion in colon cancer by suppressing CD8+ T cells via the calcineurin-NFAT pathway.
    • Targeting the calcineurin-NFAT axis could be a potential therapeutic strategy to enhance anti-tumor immunity in colorectal cancer.